Accent Capital Management’s Sanofi SNY Stock Holding History

Accent Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-531	Closed	-$29.4K	–	417
2025 Q1	$29.4K	Buy	+531	New	+$28.7K	0.02%	131

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Accent Capital Management's SNY Position: Q2 2025 in Review

Accent Capital Management sold out of Sanofi (SNY) in Q2 2025, closing a stake of 531 shares — an estimated $29.4K sold.

Accent Capital Management first reported a position in SNY in Q1 2025 and held it in 1 quarter. The position peaked at $29.4K in Q1 2025. 729 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

Accent Capital Management reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
Accent Capital Management sold 531 Sanofi shares in Q2 2025, an estimated $29.4K.
Accent Capital Management first reported a position in Sanofi in Q1 2025 and held it in 1 quarter.
Accent Capital Management's Sanofi position peaked at $29.4K in Q1 2025.
729 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Accent Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.